Applications of N-(2-Bromoethyl)Phthalimide in Industrial Manufacturing

N-(2-Bromoethyl)Phthalimide plays a crucial role as an advanced intermediate in several specialized industrial sectors. As an experienced manufacturer, we provide this compound to formulators driving innovation and compliance in the fields of pharmaceuticals, crop protection synthesis, specialty polymers, and fine chemicals. Below we detail its real-world applications across four major downstream scenarios, with technical focus on compliance, formulation standards, integration into production workflows, and resulting finished goods.

1. Pharmaceutical Intermediate for Anticonvulsant APIs

Leading pharmaceutical manufacturers rely on our material as a key building block during the synthesis of certain anticonvulsant active pharmaceutical ingredients, including those in the phthalimide class. The compound’s brominated ethyl group allows controlled introduction of nitrogen and functionalized side-chains, supporting targeted molecular modifications that are critical for CNS-active agents. Usage parameters depend on the type of API and specific synthetic pathway employed, with strict adherence to pharmacopoeia standards at all production stages.

Industry compliance standards

• ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
• European Pharmacopoeia Monograph 01/2017:0551 (where relevant)
• USP/NF Monographs for phthalimide derivatives
• FDA 21 CFR 210/211 (cGMP for finished pharmaceuticals)

Typical usage ratio

• 0.3–0.8 molar equivalents per batch, adjusted based on target yield and downstream purification requirements

Downstream process integration

• Introduced during the initial alkylation step in multi-stage API synthesis, followed by hydrazinolysis and functional group modification as per the target molecule's profile

Final product types

• Anticonvulsant drug substances (e.g., related to ethotoin or phenytoin analogs)
• Pharmaceutical intermediates registered with global regulatory agencies

2. Synthesis of Alkylating Agents for Oncology Research Compounds

Contract research organizations and bulk API manufacturers incorporate this phthalimide derivative as a precursor for the preparation of alkylating agents used in small-scale production of research and preclinical oncology compounds. Its unique chemical reactivity facilitates N-alkylation and functionalization steps that produce targeted chemotherapeutic building blocks. Material traceability and process documentation remain critical throughout the supply chain to support regulatory review.

Industry compliance standards

• OECD Principles of Good Laboratory Practice (GLP) for preclinical research
• ISO 9001:2015 Quality Management Systems for synthesis facilities
• REACH Annex XVII (Europe) for controlled intermediates
• FDA QSR 21 CFR 820 for clinical test substances (where applicable)

Typical usage ratio

• 0.15–0.5 molar ratio, adjusted for target alkylation efficiency and minimized byproduct formation

Downstream process integration

• Used after initial substrate protection/deprotection steps, followed by nucleophilic substitution or ring-closing reactions to yield functionalized oncological scaffolds

Final product types

• Preclinical alkylating agents for tumor cell line screening
• Reference standards for cytostatic development studies

3. Intermediate in Crop Protection Active Ingredient Manufacturing

Within the agrochemical sector, technical teams use our raw material as an intermediate when synthesizing certain phthalimide-derived herbicide and fungicide actives. Its bromoethyl moiety delivers consistent alkylation, which helps downstream processors obtain reproducible yields and maintain final product purity well within FAO/WHO technical grade specifications. Manufacturers prioritize compliance with international pesticide regulations throughout the lifecycle of the synthetic route.

Industry compliance standards

• FAO/WHO Specifications and Evaluations for Plant Protection Products
• ISO 17025:2017 for analytical laboratories
• EU Regulation (EC) No 1107/2009 on plant protection products
• China GB/T 17799 (as applicable for technical materials)

Typical usage ratio

• 5–10% by weight of target intermediate synthesis charge, with process optimization according to conversion completeness and impurity control

Downstream process integration

• Charged during N-alkylation of core phthalimide substrate, then subjected to hydrolysis, recovery, and optional nitration or methylation, prior to technical formulation blending

Final product types

• Active ingredients for herbicidal and fungicidal formulations
• Technical concentrates destined for wettable powders or EC formulations

4. Functional Additive Precursor for Specialty Polymers

Producers specializing in custom resins and specialty polymer applications utilize this compound as a monomeric precursor to introduce imide and alkyl side groups, which impart improved chemical resilience and tailored reactivity. The raw material’s integration supports development protocols for high-performance engineering plastics, with quality assurance protocols aligned to advanced materials manufacturing requirements in electronics and automotive.

Industry compliance standards

• ISO 9001:2015 for polymer production control
• RoHS Directive 2011/65/EU for restricted substances in electrical/electronic applications
• UL 94 (flammability classification for plastics)
• ASTM D638 (tensile properties testing for plastics)

Typical usage ratio

• 1–3% by total monomer feed in batch or continuous copolymerization, adaptable to desired imide group content and matrix compatibility

Downstream process integration

• Introduced during solution-phase or melt polymerization, often prior to curing, to achieve covalent integration of functional groups into the polymer backbone

Final product types

• Imide-modified engineering resins for electronic housings
• Automotive structural plastics with enhanced chemical resistance
• Specialty heat-resistant coatings and films